The healthcare industry is constantly seeking to address patients’ unmet well-being needs for a variety of acute and chronic diseases. Concurrently, governments are attempting to keep healthcare spending sustainable, while granting equal access to high-quality care. With the rising prevalence of several diseases, the home diagnostics market is trending for its convenience for the patient as well as hospital facilities. Some diagnostic tools provide clinicians with the ability to collect important data points remotely. Health data that can be gathered via home testing includes blood pressure, pulmonary testing, dermatological diagnosis, and neurological testing. With easy access to healthcare at doorsteps, the global home diagnostics market is anticipated to rise during the forecast period.
Diagnostics deliver information that can benefit patients by enabling the adoption of the right treatment, helping health experts to choose relevant preventive interventions and giving vital prognostic data that can optimize care pathways and administration. However, home diagnostics has a varied history. It was initially developed to offer patients sensitive testing in the secrecy of their own homes. The field has expanded greatly since the first at-home pregnancy tests became available in the 1970s. Presently, highly customized home collection kits allow patients to collect and submit their biological samples directly for laboratory testing, eliminating the need for clinicians to manage the preparation, packaging, and shipping of samples.
The COVID-19 pandemic has restricted people to their homes, restraining travel and non-essential outdoor activities for months. However, with the implementation of lockdowns in several countries, people are sheltering at homes, which is increasing the demand for home diagnostic services. Moreover, people are now hesitant to visit hospitals, clinics, and pathology labs for diagnostics tests due to the fear of the pandemic spreading in such places. As a result, the demand for home-based diagnostics, medical check-ups, and lab tests has increased considerably since the outbreak. As COVID-19 necessitates a remote approach to clinical research, clinical trial managers and clinical service providers must work together to manage the fast-changing needs of the trial landscape.
As more people were forced to stay at home, the need for more home diagnostic services has increased rapidly. The need has always been there, as many vulnerable patients existed even before the coronavirus outbreak. However, the numbers were smaller. With the pandemic of this scale, many people are realizing the benefits of home diagnostics, which is driving the home diagnostics market. In addition, as the number of diseases will still exist after the post-pandemic period, the demand for the home diagnostics market is anticipated to grow during the forecast period.
During the previous years, the market has encountered a slew of investments by various start-up companies and businesses seeking to introduce innovative technological advancements, indicating extensive research and development initiatives. Besides, the home diagnostics market endured credible incentives from the COVID-19 pandemic, as a standard shift toward preventive healthcare was witnessed. The declining footfall in hospitals amid the fear of potential COVID-19 infection has compelled patients with chronic ailments to seek home-based treatment. In addition, producers are effectively leveraging technological advancements by introducing smart solutions, including Big Data analytics, artificial intelligence, and cloud computing for data assimilation and disbursement of treatment, leading to significant disruptions in the landscape.
Regionally, due to the increasing prevalence of various lifestyle-associated and infectious diseases such as obesity, diabetes, cancer, and STDs in North America, the region is most likely to hold a prominent share of the global home diagnostics market.
Moreover, rising consumer awareness in Europe and enhancing lifestyles are projecting the regional market to grow at a high CAGR during the forecast period. Overall, the global home diagnostics market is projected to expand at a CAGR of 4.4% from 2021 to 2031.
Analysts’ Viewpoint
Businesses are discovering lucrative development potential across emerging markets, particularly in Asia. India is anticipated to yield immense development opportunities, given the exponential population growth experienced in the past few years. The global home diagnostics market is observing a high growth rate and expected to continue to expand in the near future due to the rising disposable income of people across nations, which enable them to afford products for self-care.
Home Diagnostics Market – Segmentation
| Type |
|
| Sample Type |
|
| Distribution Channel |
|
| Region |
|
The global home diagnostics market was worth US$ 5.34 Bn and is projected to reach a value of US$ 8.52 Bn by the end of 2031
Home diagnostics market is anticipated to grow at a CAGR of 4.4% during the forecast period
North America accounted for a major share of the global home diagnostics market
Home Diagnostics Market is driven by rise in demand for early disease detection and diagnosis, availability of personalized medicines, growth in prevalence of various lifestyle-associated and infectious diseases
Key players in the global home diagnostics market include SelfDiagnostics, F. Hoffmann-La Roche Ltd., Trinity Biotech Plc, Bionime Corporation, ARKRAY, Inc., ACON Laboratories, Inc., Assure Tech.(Hangzhou) Co., LTD., Abbott, Becton Dickinson & Company, and Quidel Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Home Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Home Diagnostics Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Home Diagnostics Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
6.3.1. Glucose Monitoring
6.3.2. Cholesterol Detection
6.3.3. Pregnancy
6.3.4. Allergies & Intolerances
6.3.5. Infectious Disease Testing
6.3.6. Fertility, Ovulation, and Sexual Health
6.3.7. Drug Abuse Testing
6.4. Global Home Diagnostics Market Attractiveness Analysis, by Type
7. Global Home Diagnostics Market Analysis and Forecast, by Sample Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
7.3.1. Blood
7.3.2. Urine
7.3.3. Others
7.4. Global Home Diagnostics Market Attractiveness Analysis, by Type
8. Global Home Diagnostics Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
8.3.1. Retail
8.3.2. Online
8.3.3. Others
8.4. Global Home Diagnostics Market Attractiveness Analysis, by Distribution Channel
9. Global Home Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Home Diagnostics Market Attractiveness Analysis, by Region
10. North America Home Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
10.2.1. Glucose Monitoring
10.2.2. Cholesterol Detection
10.2.3. Pregnancy
10.2.4. Allergies & Intolerances
10.2.5. Infectious Disease Testing
10.2.6. Fertility, Ovulation, and Sexual Health
10.2.7. Drug Abuse Testing
10.3. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
10.3.1. Blood
10.3.2. Urine
10.3.3. Others
10.4. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
10.4.1. Retail
10.4.2. Online
10.4.3. Others
10.5. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Sample Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Home Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
11.2.1. Glucose Monitoring
11.2.2. Cholesterol Detection
11.2.3. Pregnancy
11.2.4. Allergies & Intolerances
11.2.5. Infectious Disease Testing
11.2.6. Fertility, Ovulation, and Sexual Health
11.2.7. Drug Abuse Testing
11.3. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
11.3.1. Blood
11.3.2. Urine
11.3.3. Others
11.4. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
11.4.1. Retail
11.4.2. Online
11.4.3. Others
11.5. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Home Diagnostics Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Sample Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Home Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
12.2.1. Glucose Monitoring
12.2.2. Cholesterol Detection
12.2.3. Pregnancy
12.2.4. Allergies & Intolerances
12.2.5. Infectious Disease Testing
12.2.6. Fertility, Ovulation, and Sexual Health
12.2.7. Drug Abuse Testing
12.3. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
12.3.1. Blood
12.3.2. Urine
12.3.3. Others
12.4. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
12.4.1. Retail
12.4.2. Online
12.4.3. Others
12.5. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Home Diagnostics Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Sample Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Home Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
13.2.1. Glucose Monitoring
13.2.2. Cholesterol Detection
13.2.3. Pregnancy
13.2.4. Allergies & Intolerances
13.2.5. Infectious Disease Testing
13.2.6. Fertility, Ovulation, and Sexual Health
13.2.7. Drug Abuse Testing
13.3. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
13.3.1. Blood
13.3.2. Urine
13.3.3. Others
13.4. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
13.4.1. Retail
13.4.2. Online
13.4.3. Others
13.5. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Home Diagnostics Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Sample Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Home Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
14.2.1. Glucose Monitoring
14.2.2. Cholesterol Detection
14.2.3. Pregnancy
14.2.4. Allergies & Intolerances
14.2.5. Infectious Disease Testing
14.2.6. Fertility, Ovulation, and Sexual Health
14.2.7. Drug Abuse Testing
14.3. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
14.3.1. Blood
14.3.2. Urine
14.3.3. Others
14.4. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
14.4.1. Retail
14.4.2. Online
14.4.3. Others
14.5. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Home Diagnostics Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Sample Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. ACON Laboratories, Inc.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. ARKRAY, Inc.
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Assure Tech. (Hangzhou) Co., LTD.
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Becton Dickinson & Company
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Bionime Corporation
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. F. Hoffmann-La Roche Ltd.
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Quidel Corporation
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. SelfDiagnostics
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Trinity Biotech plc
15.3.10.1. Company Overview
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 03: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 08: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 12: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 16: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 17: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 20: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 24: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figure
Figure 01: Global Home Diagnostics Market Value Share, by Type, 2020
Figure 02: Global Home Diagnostics Market Value Share, by Sample Type, 2020
Figure 03: Global Home Diagnostics Market Value Share, by Distribution Channel, 2020
Figure 04: Global Home Diagnostics Market Value Share, by Region, 2020
Figure 05: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Type, 2020 and 2031
Figure 06: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Type, 2021–2031
Figure 07: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Glucose Monitoring, 2017–2031
Figure 08: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Cholesterol Detection, 2017–2031
Figure 09: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Pregnancy, 2017–2031
Figure 10: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Allergies & Intolerances, 2017–2031
Figure 11: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031
Figure 12: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Fertility, Ovulation & Sexual Health, 2017–2031
Figure 13: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Drug Abuse Testing, 2017–2031
Figure 13: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Drug Abuse Testing, 2017–2031
Figure 14: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 15: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–20
Figure 16: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031
Figure 17: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031
Figure 18: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031
Figure 19: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 20: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 21: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Retails, 2017–2031
Figure 22: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Online, 2017–2031
Figure 23: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031
Figure 24: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Region, 2020 and 2031
Figure 25: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Region, 2021–2031
Figure 26: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 27: North America Direct-to-Consumer Laboratory Testing Market Value Share, by Country, 2020 and 2031
Figure 28: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country, 2021–2031
Figure 29: North America Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031
Figure 30: North America Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031
Figure 31: North America Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 32: North America Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 33: North America Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 34: North America Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 35: Europe Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 36: Europe Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031
Figure 37: Europe Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 38: Europe Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031
Figure 39: Europe Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031
Figure 40: Europe Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 41: Europe Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 42: Europe Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 43: Europe Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 44: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 45: Asia Pacific Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031
Figure 46: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 47: Asia Pacific Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031
Figure 48: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031
Figure 49: Asia Pacific Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 50: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 51: Asia Pacific Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 52: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 53: Latin America Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 54: Latin America Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031
Figure 55: Latin America Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 56: Latin America Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031
Figure 57: Latin America Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031
Figure 58: Latin America Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 59: Latin America Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 60: Latin America Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 61: Latin America Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 62: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 63: Middle East & Africa Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031
Figure 64: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 63: Middle East & Africa Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031
Figure 64: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 65: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031
Figure 66: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031
Figure 67: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 68: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 69: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 70: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 71: Position Analysis, 2020, by Tier and Size of the Company
Figure 72: Breakdown of Net Sales (%), by Business Segment, 2020
Figure 73: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 74: Breakdown of Net Sales (%), by Business Segment, 2020
Figure 75: Breakdown of Net Sales (%), by Region, 2020
Figure 76: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Home Diagnostics Market Insights, 2021-2031
